Children with acute lymphoblastic leukaemia (ALL) are at increased risk for
thromboembolism (TE). Identification of a susceptible population is crucial for effective …

Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. With the
advent of aggressive multimodality therapy, ALL has become a curable disease for majority …

Essentials• Children with acute lymphoblastic leukemia (ALL) are at risk of
thromboembolism (TE).• This is a prospective evaluation of the incidence, risk factors and …

Background Thromboembolism (TE) is a serious complication in children with acute
lymphoblastic leukemia (ALL). The incidence of symptomatic thromboembolism is as high as …

Background/objectives Although thromboembolism (TE) is a serious complication in patients
with acute lymphoblastic leukemia (ALL), thromboprophylaxis is not commonly used due to …

Alterations in hemostasis leading to symptomatic thromboembolism have been observed in
patients with acute lymphoblastic leukemia (ALL) receiving Escherichia coli asparaginase …

The risk of thrombosis in children with acute lymphoblastic leukemia (ALL) reportedly ranges
between 1% and 37%. Epidemiologic studies have usually been hampered by small …

Among risk factors for developing thromboembolism (VTE) in children with acute
lymphoblastic leukemia were Escherichia coli asparaginase, concomitant steroid use …

Background Children with acute lymphoblastic leukemia (ALL) have increased risk of
thromboembolism (TE). However, the predictors of ALL‐associated TE are as yet uncertain …

Thromboembolism frequently occurs during acute lymphoblastic leukemia (ALL) therapy.
We prospectively registered thromboembolic events during the treatment of 1772 …